Noble Africa, ASPI Subsidiary, to Merge with ENDRA, Securing $50M Financing for Helium Platform
ASPI sits 86% above its 52-week low of $3.92 on light trading volume (0.1× avg).
Summary
ASP Isotopes announced a proposed merger of its wholly-owned subsidiary, Noble Africa, with ENDRA Life Sciences. Noble Africa, which holds ASPI's Renergen helium assets, will become a Nasdaq-listed helium platform. The transaction includes a concurrent $50 million private placement, with ASPI investing $20 million, providing critical capital for project development. This strategic move follows recent positive developments for ASPI's Renergen subsidiary, including new helium contracts, but also prior reports of significant cash burn. ASPI is expected to own approximately 89% of the combined company, while pre-closing ENDRA stockholders will own about 3%. The deal is expected to close in Q3 or Q4 2026, pending regulatory and stockholder approvals.
At the time of this announcement, ASPI was trading at $7.31 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $920.4M. The 52-week trading range was $3.92 to $14.49. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.